Navigation Links
ResearchDx and BioSmartSA Announce New Consulting Practice in Saudi Arabia

ResearchDx, the premier Contract Diagnostics Organization (CDO) for the biopharmaceutical industry, and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership to bring their expertise in navigating the design and management of diagnostic services to healthcare providers in the Kingdom of Saudi Arabia (KSA).

The partnership addresses the specific needs of the KSA healthcare sector—recognized throughout the Middle East as a leader in the use of accreditation to improve healthcare—in the preparatory phase for new accreditation standards set to take effect in 2020. The firms will collaborate to provide market-tailored services in clinical research, clinical trial support, laboratory regulatory services, diagnostic development, kit and reagent manufacturing, and early-stage support. ResearchDx will administer services, while BioSmartSA will lend market expertise in Saudi Arabia and throughout the Middle East.

ResearchDx, founded in 2008 by Dr. Philip D. Cotter and Dr. Mathew W. Moore, provides comprehensive consulting for the diagnostics development process— from initial assay concept and discovery through clinical research and regulatory approval. As a Contract Diagnostics Organization (CDO), ResearchDx offers clients an integrated outsource solution to guide the rapid development, manufacture and commercialization of diagnostic assays. ResearchDx delivers simplicity as a one-stop-shop for the coordination of essential partner services such as international regulators, Contract Research Organizations (CROs), clinical services and manufacturers.

BioSmartSA, founded in 2016 by Saudi Arabia’s top consultant scientists, provides quality improvement programs, accreditation and service establishment within best practice guidelines to clinical laboratories, hospitals and blood banks. BioSmartSA performs comprehensive compliance and standards assessments of partner organizations to design and execute custom work plans that reach all quality targets.

This alliance comes as healthcare providers in the KSA enter a critical phase of preparation for the 3rd Edition of National Standards for Hospitals. All providers must meet the new standards by 2020 in order to receive accreditation from the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI). The new guidelines arrive at a critical juncture for Saudi Arabian healthcare; spending is set to reach SR174 billion by 2017 amidst unprecedented demand from a growing, aging populace. The new guidelines continue the established CBAHI practice of using accreditation to promote the continuous improvements that maintain costs and improve patient outcomes. ResearchDx and BioSmartSA, through their alliance, offer KSA healthcare providers a knowledge base pivotal to navigate the new standards.

“Everyone at ResearchDx recognizes the value common standards bring patients, and the Saudi Ministry of Health has been at the forefront of using common standards to drive improvements in care,” said Philip D. Cotter, Principal, ResearchDx. “It is more important than ever that providers in the Kingdom have access to the research and diagnostics services relied upon to set global benchmarks for improving healthcare outcomes. That is why we are so excited to partner with BioSmartSA and offer our combined expertise in the Kingdom.”

“Our scientists here at BioSmartSA can collectively count scores of successful accreditation processes as experience, and have been instrumental to the advances the KSA healthcare sector made over the last two decades,” said the BioSmartSA chief clinical scientist. “Our partnership with ResearchDx realizes a joint goal of harmonizing the clinical laboratory practice of thorough standardization and accreditation while delivering exceptional service throughout the accreditation journey."

About ResearchDx
ResearchDx was founded to equip biopharmaceutical companies with the knowledge and expertise to develop and manufacture the next generation of companion diagnostic products. As the preeminent Companion Diagnostics Organization, ResearchDx offers management services for every stage of the diagnostic development process—from initial assay concept and discovery through clinical research and international regulatory approval. Learn how ResearchDx personalizes medicine at

About BioSmartSA
BioSmartSA offers specialized service and quality consultation to clinical laboratories in the public and private sectors. With dozens of successful accreditation processes as experience, BioSmartSA scientists provide service consultations tailored to address client needs in the preparation of scientific and operational proposals for new service and benchmarking, quality and accreditation evaluation, and preparation for accreditation inspections.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting Bench to Bedside" Strategies for Disease Treatment
2. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
3. Annual Conference about Technology Solutions for People with Disabilities Announces Program
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. Verenium Announces Preliminary Financial Results For Fiscal 2012
6. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
7. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
8. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
9. EAG Announces New General Manager of Release-To-Production (RTP) Division
10. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
11. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
Breaking Biology Technology:
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert ... a media edge server, the M820, which features the company,s hybrid ... software provided by Tera Probe, Inc., will be showcased during the ... the NAB show at the Las Vegas ... ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
Breaking Biology News(10 mins):